Interestingly, other than the expected associations with tumour type and MSI status, the only significant predictor of IFNγ response were JAK1 LOF mutations, which predicted substantially reduced activity (β = −0.72, p = 2.48e‐07) (Figure 4E). This evidence concerns the gene JAK1 and neoplasm.